{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-167868","form_type":"8-K","ticker":"TEVA","cik":"0000818686","company_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","filed_at":"2023-06-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.351321+00:00","generated_at":"2026-06-14T00:45:38.116227+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Teva shareholders reject advisory vote on executive compensation at 2023 annual meeting","bullets":["Elected directors Sol J. Barer and Janet S. Vergis with ~490M and ~498M votes for, respectively.","Say-on-pay proposal failed: 319.2M for, 324.5M against, showing majority disapproval.","Auditor Kesselman & Kesselman (PwC) ratified with 712.7M votes for, 35.8M against.","Approximately 103.9M broker non-votes on director and say-on-pay items."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-167868","json":"https://secwatch.observer/filing/0001193125-23-167868.json","markdown":"https://secwatch.observer/filing/0001193125-23-167868.md","text":"https://secwatch.observer/filing/0001193125-23-167868.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818686/000119312523167868/0001193125-23-167868-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818686/000119312523167868/d514530d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T00:45:38.116227+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1ec6b1d55a9883cfe9b56c5e9eaf3ab6cc5fa5e3","claim":"TEVA PHARMACEUTICAL INDUSTRIES LTD shareholders approved Ratification of appointment of Kesselman & Kesselman (PwC) as independent auditor at the 2023-06-15 meeting.","evidence_excerpt":"The shareholders approved the appointment of Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva's independent registered public accounting firm until Teva's 2024 annual meeting of shareholders, as follows: For Against Abstain Brokers non-vote 712,745,286 35,777,701 1,019,646 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/818686/000119312523167868/0001193125-23-167868-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"3265c2310a284bf1d9bd984794c3fa769c575cc4","claim":"TEVA PHARMACEUTICAL INDUSTRIES LTD shareholders rejected Non-binding advisory vote on executive compensation at the 2023-06-15 meeting.","evidence_excerpt":"The shareholders did not approve, on a non-binding advisory basis, the compensation for Teva's named executive officers listed in the proxy statement for the Annual Meeting, as follows: For Against Abstain Brokers non-vote 319,197,368 324,474,010 5,417,079 103,855,164","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/818686/000119312523167868/0001193125-23-167868-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"failed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"a88e8d78cc207394c91254b0ae86f669a7b631e9","claim":"TEVA PHARMACEUTICAL INDUSTRIES LTD shareholders approved Election of Directors at the 2023-06-15 meeting.","evidence_excerpt":"The shareholders elected to appoint the following persons to the Board, to serve until Teva's 2026 annual meeting of shareholders, as follows: Directors For Against Abstain Brokers non-vote Dr. Sol J. Barer 490,224,315 153,968,878 4,893,082 103,855,164 Janet S. Vergis 498,422,096 145,733,938 4,930,241 103,855,164","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/818686/000119312523167868/0001193125-23-167868-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}